Jan 20, 2023, 01:00 AM by User Not Found

Bio-IT World | NVIDIA is the only semiconductor manufacturer to ever present at the J.P. Morgan Healthcare Conference, said Harlan Sur, the firm’s semiconductor analyst in his introduction of Kimberly Powell, NVIDIA’s VP of healthcare. This year—NVIDIA’s fourth year presenting at the conference—Powell emphasized why NVIDIA is a crucial part of the healthcare ecosystem.

Jan 19, 2023, 10:14 AM by

Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina

Jan 19, 2023, 10:14 AM by

CureSearch for Children's Cancer is collaborating with Children's Oncology Group (COG), Labcorp Drug Development, Pfizer, UTHealth Houston School of Public Health, and Thermo Fisher Scientific on a new study to examine the economic and treatment benefits of molecular testing for childhood cancer patients.

Jan 19, 2023, 10:12 AM by

Orbita, a leading provider of intelligent virtual assistants and workflow automation for healthcare, launched a new solution set to transform the healthcare website experience. Orbita Blaze uses conversational AI and advanced search technology to interpret and address patients’ requests promptly and with precision, so they access the information and care they need.

Jan 19, 2023, 01:00 AM by User Not Found

Bio-IT World | The time it takes food to travel from the mouth to the rectum may change the metabolism of microbes in the gut. That’s one of the intriguing possibilities raised by a stool energy density study on overweight Danes recently completed by researchers at the University of Copenhagen, reports Henrik Roager, associate professor in the department of nutrition, exercise and sports.

Jan 18, 2023, 09:32 AM by

The Bill & Melinda Gates Foundation awarded VisualDx a new grant to develop diagnostic tools for surveillance, detection, and triage of Neglected Tropical Diseases (NTDs) and other rare infectious diseases in India and Nigeria. This project comes on the heels of similar public health collaborations with HHS and the state of Vermont. It also marks the second Gates Foundation grant VisualDx has received, following a successful 2020 project in Botswana to provide an offline version of its clinical decision support tool for users in remote areas.

Jan 18, 2023, 09:32 AM by

Transition to modern digital pathology will improve patient care and enable new research breakthroughs

Jan 18, 2023, 09:31 AM by

About Biopharma PEG As a leading manufacturer of PEG derivatives, Biochempeg is dedicated to being your most reliable partner to provide a chemical synthesis and high-quality PEG linkers. We are committed to promoting the progress of your ADC discovery and development projects. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/

Jan 17, 2023, 10:39 AM by

Greenphire Appoints Owen Newman as CFO to Accelerate Company Growth. The 25-year veteran brings deep expertise in financial management as the need for site and patient-centric solutions for clinical trials increases.

Jan 17, 2023, 10:28 AM by

Tune Therapeutics, a biotechnology company pioneering the creation of genetic tuning (epigenomic editing) therapies, today announced the addition of John McHutchison AO, MD – former CEO at Assembly Biosciences, Inc., and CSO at Gilead Sciences, Inc. – to its board of directors.

Jan 17, 2023, 10:25 AM by

Jan 17, 2023, 10:24 AM by

Jan 17, 2023, 10:23 AM by

OncoDxRx’s one-of-a-kind liquid biopsy PGA platform is a breakthrough backed by comprehensive profiling of cancer pathways and anti-cancer drugs.

Jan 17, 2023, 01:00 AM by User Not Found

Bio-IT World | In a paper published late last year in Nature Communications, researchers from Penn Medicine and Intel Labs report on what they call the largest to-date global federated learning effort to develop an accurate and generalizable machine learning model for detecting glioblastoma borders. The work has important implications both clinically and as a model for future large, federated learning projects.

Jan 16, 2023, 10:25 AM by

Jan 16, 2023, 10:21 AM by

Jan 16, 2023, 10:17 AM by

Jan 16, 2023, 10:16 AM by

Jan 16, 2023, 10:15 AM by

FAIRE grants provide access to the Cambridge Structural Database, software and training. The Frank H. Allen International Research & Education Programme (FAIRE) provides long-term grants to enable academic research in structural chemistry in over 80 eligible countries. Launched in 2017, the number of research and educational institutions with a FAIRE license nearly doubled in 2022 to 31. The initiative has supported researchers to publish over 100 scientific publications in primary research journals since its launch. With research and education organisations in over 80 countries eligible to apply, the FAIRE programme has the potential to greatly widen its positive impact and new applications are welcomed. Continued engagement with the structural science community through conferences like the Pan African Conference on Crystallography (PCCr3) currently being held in Nairobi, Kenya, aims to grow and further support the FAIRE community.

Jan 13, 2023, 10:10 AM by

With SmartRenewal, DrFirst Takes Aim at the Dangers of Entering Medication Renewals by Hand